Table 1. Clinical characteristics of living patients in the cataract family.
Patient | Gender | Age at diagnosis (years) | BCVA before surgery (OD, OS) | Cataract type (OU) | Surgery (Y/N) | BCVA after surgery (OD, OS) |
---|---|---|---|---|---|---|
Ⅱ-1 | F | 9 | – | – | Y | 20/160, 20/125 |
Ⅱ-4 | F | 12 | 20/40, 20/32 | Nuclear pulverulent | N | NA |
Ⅱ-8 | M | 4 | 20/100, LP | Nuclear pulverulent | Y | 20/40, FC |
Ⅲ-1 | M | 47 | 20/25, 20/20 | Peripheral cortical punctate | N | NA |
Ⅲ-5 | M | 6 | 20/40, 20/40 | Nuclear pulverulent | Y | 20/20, 20/20 |
Ⅲ-6 | M | 7 | 20/40, 20/50 | Nuclear pulverulent | Y | 20/16, 20/16 |
Ⅲ-9 | M | 6 | 20/40, 20/66 | Nuclear pulverulent | Y | 20/28, 20/25 |
Ⅳ-1 | M | 22 | 20/20, 20/20 | Peripheral cortical punctate | N | NA |
Ⅳ-3 | M | 3 | 20/30, 20/25 | Nuclear pulverulent | N | NA |
Ⅳ-5 | M | 2 | 20/125, 20/125 | Nuclear and Y-sutural | N | NA |
BCVA: best corrected visual acuity; OD: eye, oculus dexter; OS: eye, oculus sinister; OU: eye, oculus uterque; Y: yes; N: no; F: female; M: male; LP: light perception; FC: finger counting; —: unknown; NA: not applicable.